Response Genetics, Inc (RGDXQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
+0.0000 (100.00%)
At close: Jan 5, 2026
Response Genetics Revenue
Response Genetics had revenue of $3.79M in the quarter ending March 31, 2015, a decrease of -2.68%. This brings the company's revenue in the last twelve months to $16.62M, down -8.06% year-over-year. In the year 2014, Response Genetics had annual revenue of $16.72M, down -15.56%.
Revenue (ttm)
16.62M
Revenue Growth
-8.06%
P/S Ratio
n/a
Revenue / Employee
169.55K
Employees
100
Market Cap
78.00
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2014 | 16.72M | -3.08M | -15.56% |
| Dec 31, 2013 | 19.80M | 1.06M | 5.68% |
| Dec 31, 2012 | 18.74M | -3.91M | -17.25% |
| Dec 31, 2011 | 22.64M | 1.37M | 6.42% |
| Dec 31, 2010 | 21.28M | 12.21M | 134.68% |
| Dec 31, 2009 | Pro | Pro | Pro |
| Dec 31, 2008 | Pro | Pro | Pro |
| Dec 31, 2007 | Pro | Pro | Pro |
| Dec 31, 2006 | Pro | Pro | Pro |
| Dec 31, 2005 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cyclo3pss | 366.01K |
| Integrative Health Technologies | 447.50K |
| Optigenex | 991.25K |
| HTG Molecular Diagnostics | 6.21M |
| Medivolve | 666.14K |
| Biocept | 1.36M |
| Rosetta Genomics | 2.86M |
| Arrayit | 2.82M |